NASDAQ:DBVT
DBV Technologies S.A. Stock News
$0.571
-0.123 (-17.77%)
At Close: May 09, 2024
A Tale of 2 Biotechs With Competing Peanut Allergy Treatments
06:43pm, Thursday, 16'th Apr 2020
DBV Technologies and Aimmune are at the finish line for developing novel therapies for treating peanut allergies, but each has its own twist.
DBV TECHNOLOGIE/S (NASDAQ:DBVT) Stock Rating Upgraded by Zacks Investment Research
06:30am, Thursday, 16'th Apr 2020
DBV TECHNOLOGIE/S (NASDAQ:DBVT) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a research note issued on Tuesday, Zacks.com reports. The brokerage currentl
30 Stocks Moving in Wednesday's Pre-Market Session
11:04am, Wednesday, 15'th Apr 2020
Gainers
Applied DNA Sciences, Inc. (NASDAQ: APDN) shares rose 59.3% to $7.25 in pre-market trading. Applied DNA has shipped coronavirus LinearDNA vaccine candidates to Italian...
Monthly information regarding the total number of voting rights and total number of shares of the Company
10:00am, Wednesday, 15'th Apr 2020
Monthly information regarding the.
DBV Technologies: Don't Panic - The Good, The Bad, And The Opportunity
04:44pm, Tuesday, 14'th Apr 2020
DBV Technologies' stock has taken another massive hit due to managerial missteps. Their May 15 AdComm meeting was delayed after the FDA identified questions abo
Recent Research Analysts' Ratings Updates for DBV TECHNOLOGIE/S (DBVT)
08:10am, Tuesday, 14'th Apr 2020
A number of research firms have changed their ratings and price targets for DBV TECHNOLOGIE/S (NASDAQ: DBVT): 4/8/2020 – DBV TECHNOLOGIE/S was downgraded by analysts at Zacks Investment Research fro
Ordinary and Extraordinary General Meeting of April 20, 2020 to be Held in Closed Virtual Session Due to COVID-19 Pandemic
08:01pm, Friday, 10'th Apr 2020
DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company, announced that it will hold its Ordinary and Extraordinary General Me
Ordinary and Extraordinary General Meeting of April —…, —…—… to be Held in Closed ...
12:00am, Friday, 10'th Apr 2020Citigroup Maintains Buy on DBV Technologies, Lowers Price Target to $10
12:00am, Monday, 06'th Apr 2020Best Stocks for 2020: Aimmune Therapeutics Will Rebound on FDA Approval
01:42pm, Tuesday, 31'st Mar 2020
Aimmune Therapeutics received FDA approval for its Palforzia, so AIMT stock will still be one of the best stocks in 2020.
Analysts Just Made A Major Revision To Their DBV Technologies S.A. (EPA:DBV) Revenue Forecasts
07:46am, Tuesday, 31'st Mar 2020
The analysts covering DBV Technologies S.A. (EPA:DBV) delivered a dose of negativity to shareholders today, by making...
Ordinary and Extraordinary General Meeting of April 20, 2020
08:01pm, Monday, 30'th Mar 2020
Montrouge, France, March 30, 2020 Ordinary and Extraordinary General Meeting of April 20, 2020 Procedures for Obtaining Preparatory Documents for the General Meeting.
